Patent · US Active

Compositions and methods for enhancing delivery of nucleic acids into cells and for modifying expression of target genes in cells

US8299236B2 · kind B2 · utility

2Cited by
9References
13Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 8, 2008
Grant dateOct 30, 2012
Priority date
Expiry dateJan 25, 2029

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2320/32
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Polynucleotide delivery-enhancing polypeptides are admixed or complexed with, or conjugated to, nucleic acids for enhancing delivery the nucleic acids into cells. The transported nucleic acids are active in target cells as small inhibitory nucleic acids (siNAs) that modulate expression of target genes, mediated at least in part by RNA interference (RNAi). The siNA/polypeptide compositions and methods of the invention provide effective tools to modulate gene expression and alter phenotype in mammalian cells, including by altering phenotype in a manner that eliminates disease symptoms or alters disease potential in targeted cells or subject individuals to which the siNA/polypeptide compositions are administered.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.